{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Matt Dun"}, {"accession": "MS:1000589", "name": "contact email", "value": "Matt.Dun@newcastle.edu.au"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "HMRI Cancer Research Program UoN"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Dr. Matt Dun"}, {"accession": "MS:1000589", "name": "contact email", "value": "Matt.Dun@newcastle.edu.au"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Newcastle"}]}], "description": "Mutations in the interleukin-7 receptor (IL7R) or the JAK3 kinase occur frequently in T-cell acute lymphoblastic leukemia (T-ALL) and both are able to drive cellular transformation and the development of T-ALL in mouse models. However, the signal transduction pathways downstream of JAK3 mutations remain poorly characterized. Here, we describe the phosphoproteome downstream of the JAK3(L857Q)/(M511I) activating mutations in transformed Ba/F3 lymphocyte cells and human JAK3 mutated T-ALL samples . Novel peptides shown to be downstream of mutant JAK3 regulating RNA metabolism as well as epigenetic and apoptotic processes were validated using targeted PRM proteomics.", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=b8155f988bc4458e9f47443870fb4b75"}, {"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000081327"}], "identifiers": [{"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000081327"}, {"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD007046"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "T-ALL"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "JAK3"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "L857Q"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "M511I"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "TMT10plex"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "DDA"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "PRM"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Phosphoproteomic Profiling"}], "modifications": [{"accession": "UNIMOD:21", "name": "Phospho"}, {"accession": "UNIMOD:1", "name": "Acetyl"}, {"accession": "UNIMOD:35", "name": "Oxidation"}], "publications": [{"terms": [{"accession": "PRIDE:0000412", "name": "Dataset with no associated published manuscript"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "house mouse"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "human"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/PI3K/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia"}